7-Day Trial of Sucraid for Alleviating CSID Symptoms in Subjects With Low, Moderate, and Normal Sucrase Levels

Inclusion Criteria

• •Subjects with documented disaccharidase assay levels of lactase, sucrase, maltase, and palatinase via EGD disaccharidase assay (DA) performed no more than 1 year prior to enrollment with normal histological interpretation. Eligible subjects will be enrolled into the following study groups based on their documented sucrase level.
• •DA Sucrase \< 25 (n=500)
• •DA Sucrase 25-35 (n=500)
• •DA Sucrase \>55 (n=100)
• •At the discretion of the investigator, subject is suspected of CSID and has at least one symptom of diarrhea, abdominal pain, gas/bloating, nausea, or borborygmi at least 3x per week for the past 3 months or more.
• •Subject or parent/guardian must provide informed consent/assent prior to any study procedures being performed.
• •Subject is a U.S. resident.
• •Subject is male or female, ages 6 months to 17 years old.
• •Subject/parent or guardian is willing and able to complete necessary study procedures including following study instructions, completing electronic questionnaires via a personal mobile device, attending study visits and, in the Investigator's judgment, is sufficiently stable to participate in the study.
• •Subject/ parent or guardian must be able to read or understand the English language.
• •Subject or parent/guardian must have their own Android or Apple device for BYOD.